[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Meningococcal Conjugate Vaccine Market Size, Status and Forecast 2022

October 2017 | 94 pages | ID: G33420E93E5EN
QYResearch

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Meningococcal Conjugate Vaccine market, analyzes and researches the Meningococcal Conjugate Vaccine development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
  • Sanofi Pasteur
  • Pfizer
  • GlaxoSmithKline
  • Hualan Biological Engineering
  • JN International Medical Corporation
  • Baxter International
  • Merck
  • Serum Institute of India
  • Biomed
  • Novartis
Market segment by Regions/Countries, this report covers
  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia
Market segment by Type, Meningococcal Conjugate Vaccine can be split into
  • Mono Vaccines
  • Combination Vaccines
Market segment by Application, Meningococcal Conjugate Vaccine can be split into
  • Children
  • Preteens or Teens
  • Adults
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Meningococcal Conjugate Vaccine Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF MENINGOCOCCAL CONJUGATE VACCINE

1.1 Meningococcal Conjugate Vaccine Market Overview
  1.1.1 Meningococcal Conjugate Vaccine Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Meningococcal Conjugate Vaccine Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Meningococcal Conjugate Vaccine Market by Type
  1.3.1 Mono Vaccines
  1.3.2 Combination Vaccines
1.4 Meningococcal Conjugate Vaccine Market by End Users/Application
  1.4.1 Children
  1.4.2 Preteens or Teens
  1.4.3 Adults

2 GLOBAL MENINGOCOCCAL CONJUGATE VACCINE COMPETITION ANALYSIS BY PLAYERS

2.1 Meningococcal Conjugate Vaccine Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Sanofi Pasteur
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Pfizer
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 GlaxoSmithKline
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Hualan Biological Engineering
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 JN International Medical Corporation
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Baxter International
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Merck
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Serum Institute of India
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Biomed
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Novartis
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Meningococcal Conjugate Vaccine Revenue (Value) (2012-2017)
  3.10.5 Recent Developments

4 GLOBAL MENINGOCOCCAL CONJUGATE VACCINE MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Meningococcal Conjugate Vaccine Market Size by Type (2012-2017)
4.2 Global Meningococcal Conjugate Vaccine Market Size by Application (2012-2017)
4.3 Potential Application of Meningococcal Conjugate Vaccine in Future
4.4 Top Consumer/End Users of Meningococcal Conjugate Vaccine

5 UNITED STATES MENINGOCOCCAL CONJUGATE VACCINE DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Meningococcal Conjugate Vaccine Market Size (2012-2017)
5.2 United States Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

6 EU MENINGOCOCCAL CONJUGATE VACCINE DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Meningococcal Conjugate Vaccine Market Size (2012-2017)
6.2 EU Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

7 JAPAN MENINGOCOCCAL CONJUGATE VACCINE DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Meningococcal Conjugate Vaccine Market Size (2012-2017)
7.2 Japan Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

8 CHINA MENINGOCOCCAL CONJUGATE VACCINE DEVELOPMENT STATUS AND OUTLOOK

8.1 China Meningococcal Conjugate Vaccine Market Size (2012-2017)
8.2 China Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

9 INDIA MENINGOCOCCAL CONJUGATE VACCINE DEVELOPMENT STATUS AND OUTLOOK

9.1 India Meningococcal Conjugate Vaccine Market Size (2012-2017)
9.2 India Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA MENINGOCOCCAL CONJUGATE VACCINE DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Meningococcal Conjugate Vaccine Market Size (2012-2017)
10.2 Southeast Asia Meningococcal Conjugate Vaccine Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Meningococcal Conjugate Vaccine Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
  11.1.2 EU Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
  11.1.4 China Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
  11.1.5 India Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Meningococcal Conjugate Vaccine Revenue and Growth Rate (2017-2022)
11.2 Global Meningococcal Conjugate Vaccine Market Size (Value) by Type (2017-2022)
11.3 Global Meningococcal Conjugate Vaccine Market Size by Application (2017-2022)

12 MENINGOCOCCAL CONJUGATE VACCINE MARKET DYNAMICS

12.1 Meningococcal Conjugate Vaccine Market Opportunities
12.2 Meningococcal Conjugate Vaccine Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Meningococcal Conjugate Vaccine Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Meningococcal Conjugate Vaccine Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Meningococcal Conjugate Vaccine Product Scope
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) (2012-2017)
Table Global Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Meningococcal Conjugate Vaccine Market Share by Regions in 2016
Figure United States Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Meningococcal Conjugate Vaccine Market Share by Type in 2016
Figure Mono Vaccines Market Size (Million USD) and Growth Rate (2012-2017)
Figure Combination Vaccines Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Meningococcal Conjugate Vaccine Market Share by Application in 2016
Table Key Downstream Customer in Children
Figure Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate in Children (2012-2017)
Table Key Downstream Customer in Preteens or Teens
Figure Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate in Preteens or Teens (2012-2017)
Table Key Downstream Customer in Adults
Figure Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate in Adults (2012-2017)
Table Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2016 and 2017)
Figure Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Table Sanofi Pasteur Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Sanofi Pasteur (2012-2017)
Figure Sanofi Pasteur Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Hualan Biological Engineering Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Hualan Biological Engineering (2012-2017)
Figure Hualan Biological Engineering Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table JN International Medical Corporation Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of JN International Medical Corporation (2012-2017)
Figure JN International Medical Corporation Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Baxter International Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Baxter International (2012-2017)
Figure Baxter International Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Serum Institute of India Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Serum Institute of India (2012-2017)
Figure Serum Institute of India Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Biomed Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Biomed (2012-2017)
Figure Biomed Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Meningococcal Conjugate Vaccine Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Meningococcal Conjugate Vaccine Business Revenue Market Share in 2016
Table Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Type (2012-2017)
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2012
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2013
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2014
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2015
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2016
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2017
Table Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application (2012-2017)
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2012
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2013
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2014
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2015
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2016
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Meningococcal Conjugate Vaccine
Figure United States Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2012-2017)
Figure United States Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure United States Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Figure EU Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2012-2017)
Figure EU Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure EU Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Figure Japan Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2012-2017)
Figure Japan Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure Japan Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Figure China Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2012-2017)
Figure China Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure China Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Figure India Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2012-2017)
Figure India Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure India Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Figure Southeast Asia Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Meningococcal Conjugate Vaccine Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Meningococcal Conjugate Vaccine Market Size Share by Players in 2016
Figure Southeast Asia Meningococcal Conjugate Vaccine Market Size Share by Players in 2017
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Regions (2017-2022)
Table Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Regions (2017-2022)
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Regions in 2017
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Regions in 2022
Figure United States Meningococcal Conjugate Vaccine Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Meningococcal Conjugate Vaccine Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Meningococcal Conjugate Vaccine Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Meningococcal Conjugate Vaccine Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Meningococcal Conjugate Vaccine Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Meningococcal Conjugate Vaccine Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Type (2017-2022)
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2017
Figure Global Meningococcal Conjugate Vaccine Market Size Share by Type in 2022
Table Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application (2017-2022)
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2017
Figure Global Meningococcal Conjugate Vaccine Market Size (Million USD) by Application in 2022


More Publications